| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |